الصفحة الرئيسية>>Signaling Pathways>> PROTAC>>Azido-PEG6-NHS ester

Azido-PEG6-NHS ester

رقم الكتالوجGC61869

Azido-PEG6-NHS ester عبارة عن رابط PEG ADC قابل للانقسام مكون من 6 وحدات يستخدم في تخليق اتحادات الأجسام المضادة والأدوية (ADCs)Azido-PEG6-NHS ester هو أيضًا رابط PROTAC قائم على PEG و Alkyl / ether والذي يمكن استخدامه في تخليق PROTACs

Products are for research use only. Not for human use. We do not sell to patients.

Azido-PEG6-NHS ester التركيب الكيميائي

Cas No.: 2055014-64-5

الحجم السعر المخزون الكميّة
100 mg
270٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Azido-PEG6-NHS ester is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs[2].

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].

References:
[1]. Thiele NA, et al. An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy. Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14712-14717.
[2]. John W. Babich, et al. Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies. WO2018187631A1.

مراجعات

Review for Azido-PEG6-NHS ester

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Azido-PEG6-NHS ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.